About Us

Distributors love us and doctors value our products. Responsive design begins with responsive customer service.




Our surgeon partners meet periodically with the ChoiceSpine product development team to discuss clinical challenges. Then, our product engineers go to work. The result is a new product that makes spinal surgery more successful. Our surgeons are involved in product development every step of the way, from ideation to launch.



Company News

ChoiceSpine is very excited to announce the launch of the new STRATOFUSETM & STRATOGENTM Biologics Portfolio.  Like the Stratotanker that fuels our military aircrafts, the STRATOFUSETM and STRATOGENTM Biologics lines will fuel fusion and healing for procedures throughout the body. The launch includes demineralized bone matrix putties, cancellous sponges, synthetic bone graft substitutes in both strip and putty configurations, a bioactive glass synthetic putty, structural allografts, chips, matchsticks and amniotic allograft tissue forms to provide our distributor partners and surgeons with a breadth and depth of Biologics options.


This new Biologics offering works hand-in-hand with ChoiceSpine’s ever growing spread of implants to enhance spinal fusions. With numerous volumes, geometries, and configurations of all their products, the STRATOFUSETM and STRATOGENTM lines are designed to provide proficient solutions for a wide range of surgeries.


"We are extremely excited about the launch of our Biologics Portfolio.  We wanted to come out of the gate strong so we are proud to have an offering that includes various allograft and synthetic bone graft options in addition to a full amnion offering.” commented Christy Cote, Vice President of Biologics and ChoiceSpine’s Tissue Bank Director.   “We believe the addition of a Biologics platform to our already strong product portfolio is an important strategic milestone.”


“STRATOFUSETM and STRATOGENTM exemplify our dedication to developing and distributing spinal products that are innovative and surgeon-focused,” said Rick Henson and Marty Altshuler, co-founders of ChoiceSpine.  “We look forward to continuing to serve our surgeon customers with innovative products that deliver excellent clinical outcomes.”


This rollout of a Biologics line adds to an already exciting year for ChoiceSpine, who also acquired the spinal assets of Exactech early in 2017 and has announced that it will release several new implant and biologic products by the end of the calendar year. The new implants have already started coming out, with the Harrier ALIF System being released in February.


The acquisition of Exactech expanded upon ChoiceSpine’s growing list of spinal implants. “This is a great addition to our emerging product line,” said Rick Henson, co-owner of ChoiceSpine. “We look forward to building relationships with Exactech distributors and end users, as well as extending our product offering to potential new customers.”


In addition to expanding the ChoiceSpine implant portfolio, the acquisition also increased ChoiceSpine’s international scope to include distribution channels in Spain, Portugal, and Germany.  “We currently have distribution partners in Italy and Mexico, so these new assets will immediately boost our international footprint,” noted ChoiceSpine co-owner Martin Altshuler. “This investment will continue to build the momentum behind our pursuit of becoming a prominent, full-line spinal implant provider.”



©           All Rights Reserved ©